UNITED THERAPEUTICS Corp
UTHRPharmaceutical Preparations · SIC 2834 · CIK 0001082554
Revenue FY2025
$3.18B
Net Income
$1.34B
EPS (Basic)
$30.13
Net Margin
41.9%
ROE
18.8%
Total Equity
$7.10B
Shares Out
43M
UNITED THERAPEUTICS Corp — Pharmaceutical Preparations. Figures are as reported in each year's original 10-K via SEC EDGAR XBRL company facts (FY2008–FY2025; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.
Revenue & Net Income (10Y)
Margin Trends
Investor Ownership · 7 funds in our universe
FundPosition Value% of AUMQoQ ChgWeight
Summit Street Capital Management
Summit Street Capital Management
$28.6M
4.0%
(7.2%)
Deerfield Management Company
Deerfield Management Company
$247.6M
1.3%
—
Renaissance Technologies
Renaissance Technologies
$925.8M
1.0%
(4.4%)
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management
$119.6M
0.4%
(21.3%)
Bridgewater Associates
Bridgewater Associates
$60.3M
0.0%
+0.1%
Alps Advisors
Alps Advisors
$0.8M
0.0%
+52.6%
Holocene Advisors
Holocene Advisors
$0.8M
0.0%
—
Insider Transactions
Reading stored insider transactions…